CXCR4 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, inhibition of the chemokine SDF-1 receptor CXCR4 in CML cells disrupts their direct interaction with the bone marrow niche cells what sensitizes them to BCR-ABL1 inhibitor.1